• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Conformational States of HIV-1 Reverse Transcriptase for Nucleotide Incorporation vs Pyrophosphorolysis-Binding of Foscarnet.用于核苷酸掺入与膦甲酸焦磷酸解结合的HIV-1逆转录酶的构象状态
ACS Chem Biol. 2016 Aug 19;11(8):2158-64. doi: 10.1021/acschembio.6b00187. Epub 2016 Jun 6.
2
Relationship between 3'-azido-3'-deoxythymidine resistance and primer unblocking activity in foscarnet-resistant mutants of human immunodeficiency virus type 1 reverse transcriptase.1型人类免疫缺陷病毒逆转录酶的膦甲酸钠抗性突变体中3'-叠氮-3'-脱氧胸苷抗性与引物解封活性之间的关系
J Virol. 2003 Jun;77(11):6127-37. doi: 10.1128/jvi.77.11.6127-6137.2003.
3
Interactions between HIV-1 reverse transcriptase and the downstream template strand in stable complexes with primer-template.HIV-1逆转录酶与引物-模板稳定复合物中下游模板链之间的相互作用。
PLoS One. 2008;3(10):e3561. doi: 10.1371/journal.pone.0003561. Epub 2008 Oct 30.
4
Stable complexes formed by HIV-1 reverse transcriptase at distinct positions on the primer-template controlled by binding deoxynucleoside triphosphates or foscarnet.由HIV-1逆转录酶在引物-模板的不同位置形成的稳定复合物,其受脱氧核苷三磷酸或膦甲酸结合的控制。
J Mol Biol. 2007 May 25;369(1):41-54. doi: 10.1016/j.jmb.2007.03.006. Epub 2007 Mar 12.
5
Phenotypic mechanism of HIV-1 resistance to 3'-azido-3'-deoxythymidine (AZT): increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase.人类免疫缺陷病毒1型(HIV-1)对3'-叠氮-3'-脱氧胸苷(AZT)耐药的表型机制:突变型病毒逆转录酶的聚合持续能力增强及对焦磷酸的敏感性增加。
Biochemistry. 1998 Nov 10;37(45):15908-17. doi: 10.1021/bi981200e.
6
Effects of nucleotides and nucleotide analogue inhibitors of HIV-1 reverse transcriptase in a ratchet model of polymerase translocation.核苷酸及HIV-1逆转录酶的核苷酸类似物抑制剂在聚合酶易位棘轮模型中的作用
Curr Pharm Des. 2006;12(15):1867-77. doi: 10.2174/138161206776873626.
7
Role of glutamine-151 of human immunodeficiency virus type-1 reverse transcriptase in RNA-directed DNA synthesis.人类免疫缺陷病毒1型逆转录酶的谷氨酰胺151在RNA指导的DNA合成中的作用。
Biochemistry. 1997 Nov 25;36(47):14430-8. doi: 10.1021/bi970645k.
8
Structure and functional implications of the polymerase active site region in a complex of HIV-1 RT with a double-stranded DNA template-primer and an antibody Fab fragment at 2.8 A resolution.HIV-1逆转录酶与双链DNA模板引物及抗体Fab片段复合物中聚合酶活性位点区域在2.8埃分辨率下的结构与功能意义
J Mol Biol. 1998 Dec 11;284(4):1095-111. doi: 10.1006/jmbi.1998.2208.
9
Mechanistic basis of zidovudine hypersusceptibility and lamivudine resistance conferred by the deletion of codon 69 in the HIV-1 reverse transcriptase coding region.人免疫缺陷病毒1型逆转录酶编码区密码子69缺失导致齐多夫定超敏反应和拉米夫定耐药性的机制基础
J Mol Biol. 2008 Oct 3;382(2):327-41. doi: 10.1016/j.jmb.2008.07.030. Epub 2008 Jul 17.
10
Refined model for primer/template binding by HIV-1 reverse transcriptase: pre-steady-state kinetic analyses of primer/template binding and nucleotide incorporation events distinguish between different binding modes depending on the nature of the nucleic acid substrate.HIV-1逆转录酶介导引物/模板结合的精细模型:引物/模板结合和核苷酸掺入事件的预稳态动力学分析根据核酸底物的性质区分不同的结合模式。
J Mol Biol. 1999 Sep 17;292(2):333-44. doi: 10.1006/jmbi.1999.3057.

引用本文的文献

1
A novel aptamer-based dNTP assay reveals that intact HIV virions are highly stable and do not contain enough dNTPs to support DNA synthesis.一种基于新型适配体的脱氧核苷酸三磷酸(dNTP)检测方法表明,完整的HIV病毒颗粒高度稳定,且所含的dNTP不足以支持DNA合成。
J Virol. 2025 Jul 15:e0056425. doi: 10.1128/jvi.00564-25.
2
Structural basis of deoxynucleotide addition by HIV-1 RT during reverse transcription.HIV-1逆转录酶在逆转录过程中添加脱氧核苷酸的结构基础。
Nat Commun. 2024 Dec 4;15(1):10553. doi: 10.1038/s41467-024-54618-y.
3
Small Molecule Drugs Targeting Viral Polymerases.靶向病毒聚合酶的小分子药物
Pharmaceuticals (Basel). 2024 May 20;17(5):661. doi: 10.3390/ph17050661.
4
Structural Insights into Protein-Aptamer Recognitions Emerged from Experimental and Computational Studies.从实验和计算研究中揭示出蛋白-适体识别的结构见解。
Int J Mol Sci. 2023 Nov 14;24(22):16318. doi: 10.3390/ijms242216318.
5
Transposon control as a checkpoint for tissue regeneration.转座子控制作为组织再生的检查点。
Development. 2022 Nov 15;149(22). doi: 10.1242/dev.191957. Epub 2022 Nov 28.
6
Comparative Pharmacokinetics of a Dual Inhibitor of HIV-1, NBD-14189, in Rats and Dogs with a Proof-of-Concept Evaluation of Antiviral Potency in SCID-hu Mouse Model.在 SCID-hu 小鼠模型中进行抗病毒效力的概念验证研究,评估 NBD-14189(一种 HIV-1 的双重抑制剂)在大鼠和犬体内的比较药代动力学。
Viruses. 2022 Oct 16;14(10):2268. doi: 10.3390/v14102268.
7
Cryo-EM structures of wild-type and E138K/M184I mutant HIV-1 RT/DNA complexed with inhibitors doravirine and rilpivirine.野生型和 E138K/M184I 突变 HIV-1 RT/DNA 与抑制剂地拉韦啶和利匹韦林复合物的冷冻电镜结构。
Proc Natl Acad Sci U S A. 2022 Jul 26;119(30):e2203660119. doi: 10.1073/pnas.2203660119. Epub 2022 Jul 19.
8
Human endogenous retrovirus-K (HERV-K) reverse transcriptase (RT) structure and biochemistry reveals remarkable similarities to HIV-1 RT and opportunities for HERV-K-specific inhibition.人类内源性逆转录病毒-K(HERV-K)逆转录酶(RT)的结构和生物化学与 HIV-1 RT 具有显著的相似性,为 HERV-K 特异性抑制提供了机会。
Proc Natl Acad Sci U S A. 2022 Jul 5;119(27):e2200260119. doi: 10.1073/pnas.2200260119. Epub 2022 Jun 30.
9
Structural basis of HIV inhibition by L-nucleosides: Opportunities for drug development and repurposing.HIV 抑制的 L-核苷结构基础:药物研发和再利用的机会。
Drug Discov Today. 2022 Jul;27(7):1832-1846. doi: 10.1016/j.drudis.2022.02.016. Epub 2022 Feb 23.
10
Selection of Primer-Template Sequences That Bind with Enhanced Affinity to Vaccinia Virus E9 DNA Polymerase.选择与痘苗病毒 E9 DNA 聚合酶结合增强亲和力的引物-模板序列。
Viruses. 2022 Feb 10;14(2):369. doi: 10.3390/v14020369.

本文引用的文献

1
Exploring the role of the α-carboxyphosphonate moiety in the HIV-RT activity of α-carboxy nucleoside phosphonates.探索α-羧基膦酸酯部分在α-羧基核苷膦酸酯的HIV逆转录酶活性中的作用。
Org Biomol Chem. 2016 Feb 28;14(8):2454-65. doi: 10.1039/c5ob02507a.
2
Structure of HIV-1 reverse transcriptase bound to a novel 38-mer hairpin template-primer DNA aptamer.与一种新型38聚体发夹模板-引物DNA适配体结合的HIV-1逆转录酶的结构。
Protein Sci. 2016 Jan;25(1):46-55. doi: 10.1002/pro.2776. Epub 2015 Sep 18.
3
Alpha-carboxy nucleoside phosphonates as universal nucleoside triphosphate mimics.α-羧基核苷膦酸酯作为通用的三磷酸核苷类似物。
Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):3475-80. doi: 10.1073/pnas.1420233112. Epub 2015 Mar 2.
4
Catalytic metal ions and enzymatic processing of DNA and RNA.催化金属离子与 DNA 和 RNA 的酶促加工。
Acc Chem Res. 2015 Feb 17;48(2):220-8. doi: 10.1021/ar500314j. Epub 2015 Jan 15.
5
Derivatives of mesoxalic acid block translocation of HIV-1 reverse transcriptase.中草酸衍生物可阻断HIV-1逆转录酶的转位。
J Biol Chem. 2015 Jan 16;290(3):1474-84. doi: 10.1074/jbc.M114.614305. Epub 2014 Oct 29.
6
Thermodynamics of HIV-1 reverse transcriptase in action elucidates the mechanism of action of non-nucleoside inhibitors.HIV-1 逆转录酶作用的热力学阐明了非核苷抑制剂的作用机制。
J Am Chem Soc. 2013 Jul 3;135(26):9743-52. doi: 10.1021/ja4018418. Epub 2013 Jun 18.
7
HIV-1 reverse transcriptase and antiviral drug resistance. Part 1.HIV-1 逆转录酶与抗病毒药物耐药性。第 1 部分。
Curr Opin Virol. 2013 Apr;3(2):111-8. doi: 10.1016/j.coviro.2013.03.012. Epub 2013 Apr 19.
8
HIV-1 reverse transcriptase and antiviral drug resistance. Part 2.HIV-1 逆转录酶与抗病毒药物耐药性。第 2 部分。
Curr Opin Virol. 2013 Apr;3(2):119-28. doi: 10.1016/j.coviro.2013.03.014. Epub 2013 Apr 19.
9
HIV-1 reverse transcription.HIV-1 逆转录。
Cold Spring Harb Perspect Med. 2012 Oct 1;2(10):a006882. doi: 10.1101/cshperspect.a006882.
10
HIV-1 reverse transcriptase complex with DNA and nevirapine reveals non-nucleoside inhibition mechanism.HIV-1 逆转录酶-DNA-奈韦拉平复合物揭示非核苷抑制机制。
Nat Struct Mol Biol. 2012 Jan 22;19(2):253-9. doi: 10.1038/nsmb.2223.

用于核苷酸掺入与膦甲酸焦磷酸解结合的HIV-1逆转录酶的构象状态

Conformational States of HIV-1 Reverse Transcriptase for Nucleotide Incorporation vs Pyrophosphorolysis-Binding of Foscarnet.

作者信息

Das Kalyan, Balzarini Jan, Miller Matthew T, Maguire Anita R, DeStefano Jeffrey J, Arnold Eddy

机构信息

Center for Advanced Biotechnology and Medicine (CABM), Department of Chemistry and Chemical Biology, Rutgers University , Piscataway, New Jersey, United States.

Rega Institute for Medical Research and Department of Microbiology and Immunology, KU Leuven , B-3000 Leuven, Belgium.

出版信息

ACS Chem Biol. 2016 Aug 19;11(8):2158-64. doi: 10.1021/acschembio.6b00187. Epub 2016 Jun 6.

DOI:10.1021/acschembio.6b00187
PMID:27192549
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4992415/
Abstract

HIV-1 reverse transcriptase (RT) catalytically incorporates individual nucleotides into a viral DNA strand complementing an RNA or DNA template strand; the polymerase active site of RT adopts multiple conformational and structural states while performing this task. The states associated are dNTP binding at the N site, catalytic incorporation of a nucleotide, release of a pyrophosphate, and translocation of the primer 3'-end to the P site. Structural characterization of each of these states may help in understanding the molecular mechanisms of drug activity and resistance and in developing new RT inhibitors. Using a 38-mer DNA template-primer aptamer as the substrate mimic, we crystallized an RT/dsDNA complex that is catalytically active, yet translocation-incompetent in crystals. The ability of RT to perform dNTP binding and incorporation in crystals permitted obtaining a series of structures: (I) RT/DNA (P-site), (II) RT/DNA/AZTTP ternary, (III) RT/AZT-terminated DNA (N-site), and (IV) RT/AZT-terminated DNA (N-site)/foscarnet complexes. The stable N-site complex permitted the binding of foscarnet as a pyrophosphate mimic. The Mg(2+) ions dissociated after catalytic addition of AZTMP in the pretranslocated structure III, whereas ions A and B had re-entered the active site to bind foscarnet in structure IV. The binding of foscarnet involves chelation with the Mg(2+) (B) ion and interactions with K65 and R72. The analysis of interactions of foscarnet and the recently discovered nucleotide-competing RT inhibitor (NcRTI) α-T-CNP in two different conformational states of the enzyme provides insights for developing new classes of polymerase active site RT inhibitors.

摘要

人类免疫缺陷病毒1型逆转录酶(RT)催化将单个核苷酸掺入与RNA或DNA模板链互补的病毒DNA链中;在执行此任务时,RT的聚合酶活性位点会呈现多种构象和结构状态。相关状态包括dNTP在N位点的结合、核苷酸的催化掺入、焦磷酸的释放以及引物3'端向P位点的移位。对这些状态的结构表征可能有助于理解药物活性和耐药性的分子机制,并有助于开发新的RT抑制剂。我们使用一个38聚体DNA模板-引物适配体作为底物模拟物,结晶出一种具有催化活性但在晶体中无法进行移位的RT/dsDNA复合物。RT在晶体中进行dNTP结合和掺入的能力使得能够获得一系列结构:(I)RT/DNA(P位点),(II)RT/DNA/AZTTP三元复合物,(III)RT/AZT终止的DNA(N位点),以及(IV)RT/AZT终止的DNA(N位点)/膦甲酸盐复合物。稳定的N位点复合物允许膦甲酸盐作为焦磷酸模拟物结合。在预移位结构III中催化添加AZTMP后,Mg(2+)离子解离,而在结构IV中离子A和B重新进入活性位点以结合膦甲酸盐。膦甲酸盐的结合涉及与Mg(2+)(B)离子的螯合以及与K65和R72的相互作用。对膦甲酸盐与最近发现的核苷酸竞争性RT抑制剂(NcRTI)α-T-CNP在酶的两种不同构象状态下相互作用的分析为开发新型聚合酶活性位点RT抑制剂提供了见解。